Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Cancer J. 2013 Jul-Aug;19(4):333–340. doi: 10.1097/PPO.0b013e3182a09e07

Figure 2. Examples of HDAC inhibitor activity and clinical studies in RCC.

Figure 2

Summary of the different studies conducted in vitro, in vivo and clinical trials combining HDACs with other agents. Upper panel: genes and pathways affected by HDAC inhibitors. Lower panels: combination clinical trials with HDAC inhibitors.